glp 1 and botox vs GLP-1: The Injection Hypocrisy Nobody's Talking About Aesthetic restoration following GLP-1 agonist–induced

The other approved anti-fibrotic drug, nintedanib, is a non-specific tyrosine kinase inhibitor, which prevents the phosphorylation multiple targets involved in the development of fibrosis including platelet-derived growth factor receptor (PDGFR), fibroblast growth factor receptor (FGFR), vascular endothelial growth factor receptor (VEGFR) as well as the type II TGF- receptor (105, 106)

So, its important to follow your prescribers guidance and never adjust doses on your own

81 Notably, a substantial fraction of tryptophan is directed through the Kyn pathway, culminating in the production of a suite of metabolites with significant physiological implications

Documents to bring: Insurance card and any pre-authorization reference numbers Most recent lab results (within 3 months: fasting glucose, HbA1c, lipid panel, liver enzymes, thyroid function) List of all current medications with dosages Written weight history with dates, methods tried, and outcomes Documentation of any weight-related diagnoses (hypertension, prediabetes, sleep apnea, PCOS, etc.) Printed list of questions (from the section above) Numbers to know: Your current BMI (calculate beforehand) Your highest adult weight and the date Your target weight or goal BMI range Duration of your most recent lifestyle intervention Relevant lab values (A1c, fasting glucose, blood pressure trend) Phrases to remember: "I would like to discuss GLP-1 receptor agonists as part of a comprehensive treatment plan" "My BMI is [number], and I have [comorbidity]